|
⚲
|
| Keyboard |
| Tousignant Jennifer
✚
|
|
|---|---|
| CIK # | 0002010978 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002010978] | |
| 4 | [0002010978] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Tousignant Jennifer | |
| Miragen Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2026-03-03 | Option exercise | 5,169 | ||
|
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
|
2026-03-03 | Option exercise | 5,169 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2026-03-03 | Tax withheld | 1,724 | $29.32 | 50,548 |
|
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
|
2026-03-02 | Grant | 23,850 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2026-03-02 | Grant | 119,300 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Common Stock
|
2025-12-31 | Sell | 2,272 | $31.16 | 70,796 |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2025-03-03 | Grant | 124,072 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
|
2025-03-03 | Grant | 20,679 | $0.00 | |
|
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
|
2024-02-12 | Grant | 290,000 | $0.00 |